Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glynne

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
The British Journal of Radiology|January 25, 2011
Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancerC Corner, F Khimji, Y Tsang, et al.
British Journal of Cancer|October 27, 2005
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) studyD Sebag-Montefiore, R Glynne-Jones, S Falk, et al.
European Journal of Immunology|April 1, 1993
The major histocompatibility complex-encoded proteasome component LMP7: alternative first exons and post-translational processingR Glynne, L A Kerr, I Mockridge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2012
To PET or not to PET? That is the question. Staging in anal cancerN J Bhuva, R Glynne-Jones, L Sonoda, et al.
Nature|September 26, 1991
A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHCR Glynne, S H Powis, S Beck, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 11, 2013
Radiochemotherapy in rectal cancer: the role of oxaliplatinJ P Gerard, R Glynne-Jones, W Blackstock, et al.
British Journal of Cancer|January 31, 2007
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group StudyR Glynne-Jones, S Falk, T S Maughan, et al.
Annals of Clinical Biochemistry|August 31, 2004
Iatrogenic copper deficiency following information and drugs obtained over the InternetT F Lang, R Glynne-Jones, S Blake, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2020
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trialR Glynne-Jones, H M Meadows, A Lopes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2005
A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancerR Glynne-Jones, D Sebag-Montefiore, T S Maughan, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
The British Journal of Radiology|January 25, 2011
Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancerC Corner, F Khimji, Y Tsang, et al.
British Journal of Cancer|October 27, 2005
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) studyD Sebag-Montefiore, R Glynne-Jones, S Falk, et al.
European Journal of Immunology|April 1, 1993
The major histocompatibility complex-encoded proteasome component LMP7: alternative first exons and post-translational processingR Glynne, L A Kerr, I Mockridge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2012
To PET or not to PET? That is the question. Staging in anal cancerN J Bhuva, R Glynne-Jones, L Sonoda, et al.
Nature|September 26, 1991
A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHCR Glynne, S H Powis, S Beck, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 11, 2013
Radiochemotherapy in rectal cancer: the role of oxaliplatinJ P Gerard, R Glynne-Jones, W Blackstock, et al.
British Journal of Cancer|January 31, 2007
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group StudyR Glynne-Jones, S Falk, T S Maughan, et al.
Annals of Clinical Biochemistry|August 31, 2004
Iatrogenic copper deficiency following information and drugs obtained over the InternetT F Lang, R Glynne-Jones, S Blake, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2020
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trialR Glynne-Jones, H M Meadows, A Lopes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2005
A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancerR Glynne-Jones, D Sebag-Montefiore, T S Maughan, et al.
Pageof 9